Mobidiag, Bioportugal Collaborate
News Sep 27, 2016
Mobidiag Ltd has announced an agreement with Bioportugal Química Farmacêutica Lda for the distribution of the Amplidiag® product line. Under this agreement Bioportugal becomes the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Portugal.
“For the past months, we have been extending significantly our European distribution network. With a strong background in diagnostics, Bioportugal seemed to be the clear choice to distribute our IVD tests in Portugal. We are then very pleased to expand even more Amplidiag accessibility with the support of Bioportugal” said Tuomas Tenkanen, CEO at Mobidiag.
“Bioportugal is one of the leader companies in the molecular diagnostic in Portugal and we have been supplying several branches world recognized for the last 15 years. Modidiag portfolio of products is perfect to complete our existing list. It was a gap in our portfolio and with Mobidiag range of products we expect to cover a more extensive list of clients, increase business and have a profitable relationship for both parts” said Joaquim Teixeira, CEO at Bioportugal.
The distribution agreement is effective immediately and covers all Amplidiag® products (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE, Amplidiag® Easy and upcoming Amplidiag® Viral GE).
Molecules in Spit Could Help Diagnose ConcussionsNews
Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to Penn State College of Medicine researchers.READ MORE
Breakthrough Discovery In Diagnostic Tools That Can Replace AntibodiesNews
Experts from the University of Leicester have announced the development of polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications.READ MORE
Cell-weighing Method Could Help Doctors Choose Cancer DrugsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE